Senores Pharmaceuticals
SENORESNSE

Senores Pharmaceuticals

₹821.4016.05 (1.99%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
806.10
Today’s high
828.00
52 week low
475.00
52 week high
876.50
Open price
806.10
Previous close
805.35
Live volume
2,21,627
Lower circuit
657.15
Upper circuit
985.65

Fundamentals

Market Cap
₹3,792Cr
ROE
10.70%
P/E Ratio(TTM)
36.88
EPS(TTM)
22.33
P/B Ratio
4.66
Dividend Yield
0.00%
Industry P/E
31.77
Book Value
176.75
Debt to Equity
0.30
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Senores Pharmaceuticals Limited manufactures pharmaceutical formulations and active pharmaceutical ingredients (APIs).;
MD/CEO
Swapnil Shah
Founded in
2017
NSE symbol
SENORES
Industry

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
45.82%
Retail And Others
40.93%
Mutual Funds
5.07%
Other Domestic Institutions
4.54%
Foreign Institutions
3.64%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹689.35
+8.55 (1.26%)
L
    H
    3,947.6629.813.87
    ₹418.40
    +3.40 (0.82%)
    L
      H
      3,929.6443.855.39
      Aarti DrugsAARTIDRUGS
      ₹355.10
      -2.55 (0.71%)
      L
        H
        3,237.8015.992.21
        ₹285.67
        +6.48 (2.32%)
        L
          H
          3,112.5965.0711.77
          Livesquawk
          Senores Pharma's co-promoter, Renosen Pharma, released a pledge on 400,000 shares on Feb 13.
          2026
          20
          Jan
          Quarterly Result
          Release date
          2025
          6
          Nov
          Quarterly Result
          Release date
          23
          Jul
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks